Phathom Pharmaceuticals PHAT
NASDAQ PHAT
$9.50 +0.45 (+4.98%)
As of: Sep 4, 2026 · 3:59 PM EDT

Phathom Pharmaceuticals (PHAT) Property, Plant & Equipment (Net) (2019 - 2026)

Analysis

Phathom Pharmaceuticals (PHAT) Property, Plant & Equipment (Net) (2019 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.67 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 5.46 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 1.96 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 2.06 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 34.61 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 1.64 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 554.14 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 107.22 Mn
10 Phathom Pharmaceuticals 796.85 Mn 611.51 Mn 59.18 Mn 971,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 971,000.00
Mar 31, 2026 1.02 Mn
Dec 31, 2025 1.06 Mn
Sep 30, 2025 1.16 Mn
Jun 30, 2025 1.24 Mn
Mar 31, 2025 1.35 Mn
Dec 31, 2024 1.48 Mn
Sep 30, 2024 1.66 Mn
Jun 30, 2024 1.81 Mn
Mar 31, 2024 1.96 Mn
Dec 31, 2023 2.15 Mn
Sep 30, 2023 1.98 Mn
Jun 30, 2023 1.16 Mn
Mar 31, 2023 1.28 Mn
Dec 31, 2022 1.21 Mn
Sep 30, 2022 831,000.00
Jun 30, 2022 883,000.00
Mar 31, 2022 708,000.00
Dec 31, 2021 650,000.00
Sep 30, 2021 692,000.00